TRCT
PTRAW

Tower Research Capital (TRC)’s Proterra Inc. Warrant PTRAW Stock Holding History

Tower Research Capital (TRC)’s Portfolio PTRAW Stock Details PTRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed – – 6544
2021
Q2 		$0 Buy
+50
New +$263 ﹤0.01% 6209

Other funds holding PTRAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Tower Research Capital (TRC)'s PTRAW Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Proterra Inc. Warrant (PTRAW) in Q3 2021, closing a stake of 50 shares.

Tower Research Capital (TRC) first reported a position in PTRAW in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 24 funds tracked by Wall St. Rank hold PTRAW as of Q3 2021.

  • Tower Research Capital (TRC) reported no remaining Proterra Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 50 Proterra Inc. Warrant shares in Q3 2021.
  • Tower Research Capital (TRC) first reported a position in Proterra Inc. Warrant in Q2 2021 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Proterra Inc. Warrant position peaked at $0 in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Proterra Inc. Warrant as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.